even in cases of uncomplicated TBAD, 12 and the application of this surgical technique to manage aortic dissection seems to be expanding.On the other hand, there have been only a few case series reported in the literature on the use of TEVAR for TAAD. 13-15 The use of this surgical technique for managing TAAD is complicated by multiple factors including the location of the coronary artery, involvement of arch vessels, and proximity of the aortic valve, among others, as all factors could, in theory, contribute to a potentially fatal outcome should operative complications arise. 16 The largest series reported is by Ye et al, 17 who reported the results of 45 TEVARs for Chinese patients with TAAD with excellent results. However, no large case series have been reported since, and it appears that TEVAR for TAAD is still not applicable using current devices.As a means of teasing out the anatomical problems of TAAD, a few feasibility studies have evaluated TEVAR for TAAD using the manufacturers' instructions for use S tanford type A aortic dissection (TAAD) remains the most lethal aortic emergency, with a 50% mortality rate within 48 h of onset. 1,2 The only available standard treatment is open surgical repair, 3,4 and although recent advances in perioperative management have led to improved outcomes, 5,6 TAAD is still associated with high rates of morbidity and mortality. 7-9 Moreover, because of high levels of surgical stress, approximately 20% of patients are still denied treatment. 1 Thoracic endovascular aneurysm repair (TEVAR) was originally developed as a treatment for aneurysms, but when used to close the primary entry tear (ET) of acute complicated type B aortic dissections (TBAD), it had favorable outcomes, including enlargement of the collapsed true lumen, increased flow through the true lumen, thrombus formation leading to occlusion in the false lumen, and ultimately, aortic remodeling to cure the dissection. It has already become the treatment of choice for complicated TBAD.